OTC and Huntington disease: Moreover, we confirmed that the expression of Otc (ornithine transcarbamylase) was also reduced (fold change: −3.7), which is consistent with a lower expression of OTC protein in the blood in pre-symptomatic HD patients compared to controls [34].